XML 46 R27.htm IDEA: XBRL DOCUMENT
v3.26.1

Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Significant Accounting Policies [Abstract] |
Schedule of Depreciable Rates of Property and Equipment | Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
|  | % |  |  | Mainly % |
Laboratory equipment |  | 10 |  |  | 10 |
Computers, office furniture and equipment |  | 6 - 33 |  |  | 33 |
Schedule of Major Customer Data as a Percentage | Major customer data as a percentage of total revenues:
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Cipher Pharmaceuticals (Canada) |  |  | 11 | % |  |  | 7 | % |  |  | 11 | %
Chong Kun Dang Pharmaceuticals Corp. (South Korea) |  |  | 19 | % |  |  | 11 | % |  |  | 25 | %
Gebro Holding GmbH (Austria) |  |  | 19 | % |  |  | 11 | % |  |  | 18 | %
Ewopharma AG (Switzerland) |  |  | 51 | % |  |  | 30 | % |  |  | 46 | %
Vetbiolix (France) |  |  | - | % |  |  | 41 | % |  |  | - |
Total |  |  | 100 | % |  |  | 100 | % |  |  | 100 | %
Schedule of Antidilutive Shares | All outstanding share options and warrants for the years ended December 31, 2025, 2024 and 2023 have been excluded from the calculation of the diluted net loss per share, because all such securities are anti-dilutive for all periods presented. The potential ordinary shares and warrants that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented because including them would have been anti-dilutive are as follows:
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Options |  |  | 49,533 |  |  |  | 41,610 |  |  |  | 27,492 |
Warrants |  |  | 2,604,096 |  |  |  | 886,599 |  |  |  | 617,337 |
Total |  |  | 2,653,629 |  |  |  | 928,209 |  |  |  | 644,829 |
(*) | Retroactively adjusted to give effect to the reverse share split, see also note 9.

X
- Definition The tabular disclosure for property plant. + References No definition available. + Details
Name: | canf_ScheduleOfUsefulLivesOfTheAssetTableTextBlock
Namespace Prefix: | canf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration